MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science